Medios AG, DE000A1MMCC8

Medios AG, DE000A1MMCC8

10.11.2022 - 07:51:46

EQS-News: Medios AG continues growth course in the first nine months of 2022 - guidance for the 2022 financial year confirmed

? 43,759 ? 28,207 ? 55.1 ? Pharmaceutical Supply ? 28,202 ? 23,808 ? 18.5 ? Patient-Specific Therapies ? 19,339 ? 5,983 ? 223.2 ? Services ? -3,782 ? -1,584 ? 138.7

?

Important events for Medios AG in the 2022 financial year:

November 16:?Warburg Conference ? Berlin

November 24:?Medios Capital Markets Day ? Berlin

December 07:?Berenberg European Conference 2022 ? Pennyhill Park, Surrey, Great Britain

?

1EBITDA is defined as net earnings for the period before interest, income taxes, depreciation and amortization. EBITDA pre is adjusted for extraordinary expenses for stock options and M&A activities.

?

?

About Medios AG

Medios AG is the leading provider of Specialty Pharma Solutions in Germany. As a competence partner and expert, Medios covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies.

Medios AG is Germany's first listed Specialty Pharma Company and is included in the SDAX selection index. The shares (ISIN: DE000A1MMCC8) are listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).

?www.medios.ag

?

Contact

Claudia Nickolaus

Head of Investor & Public Relations, ESG Communications

Medios AG

Heidestra?e 9 | 10557 Berlin

T +49 30 232 566 800

c.nickolaus@medios.ag

www.medios.ag

?

Anna H?ffken

Senior Consultant Investor & Public Relations

Kirchhoff Consult AG

Borselstra?e 20 |?22765 Hamburg

T +49 40 609 186 34

anna.hoeffken@kirchhoff.de

www.kirchhoff.de

?

?

Disclaimer

This communication contains forward-looking statements that are subject to certain risks and uncertainties. Future results could differ materially from those currently anticipated as a result of various risk factors and uncertainties, including, but not limited to, changes in business, economic and competitive conditions, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings and the availability of financing.

?

?

?

10.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: Medios AG Heidestra?e 9 10557 Berlin

Germany Phone: +49 30 232 566 - 800 Fax: +49 30 232 566 - 801 E-mail: ir@medios.ag Internet: www.medios.ag ISIN: DE000A1MMCC8 WKN: A1MMCC Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1483483 ? End of News EQS News Service

1483483??10.11.2022?CET/CEST

@ dgap.de